Dr Reddy's Laboratories Operating Expenses 2010-2024 | RDY
Dr Reddy's Laboratories annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Dr Reddy's Laboratories operating expenses for the quarter ending June 30, 2024 were $0.706B, a 16.5% increase year-over-year.
- Dr Reddy's Laboratories operating expenses for the twelve months ending June 30, 2024 were $2.638B, a 10.05% increase year-over-year.
- Dr Reddy's Laboratories annual operating expenses for 2024 were $2.538B, a 10.49% increase from 2023.
- Dr Reddy's Laboratories annual operating expenses for 2023 were $2.297B, a 5.74% decline from 2022.
- Dr Reddy's Laboratories annual operating expenses for 2022 were $2.437B, a 13.61% increase from 2021.
Dr Reddy's Laboratories Annual Operating Expenses
(Millions of US $) |
| 2024 |
$2,538 |
| 2023 |
$2,297 |
| 2022 |
$2,437 |
| 2021 |
$2,145 |
| 2020 |
$1,881 |
| 2019 |
$1,923 |
| 2018 |
$1,998 |
| 2017 |
$1,963 |
| 2016 |
$1,888 |
| 2015 |
$1,956 |
| 2014 |
$1,768 |
| 2013 |
$1,778 |
| 2012 |
$1,536 |
| 2011 |
$1,419 |
| 2010 |
$1,340 |
| 2009 |
$79 |
Dr Reddy's Laboratories Quarterly Operating Expenses
(Millions of US $) |
| 2024-06-30 |
$706 |
| 2024-03-31 |
$660 |
| 2023-12-31 |
$659 |
| 2023-09-30 |
$613 |
| 2023-06-30 |
$606 |
| 2023-03-31 |
$579 |
| 2022-12-31 |
$626 |
| 2022-09-30 |
$587 |
| 2022-06-30 |
$506 |
| 2022-03-31 |
$660 |
| 2021-12-31 |
$590 |
| 2021-09-30 |
$614 |
| 2021-06-30 |
$572 |
| 2021-03-31 |
$566 |
| 2020-12-31 |
$563 |
| 2020-09-30 |
$538 |
| 2020-06-30 |
$477 |
| 2020-03-31 |
$346 |
| 2019-12-31 |
$515 |
| 2019-09-30 |
$578 |
| 2019-06-30 |
$442 |
| 2019-03-31 |
$522 |
| 2018-12-31 |
$456 |
| 2018-09-30 |
$471 |
| 2018-06-30 |
$475 |
| 2018-03-31 |
$485 |
| 2017-12-31 |
$512 |
| 2017-09-30 |
$494 |
| 2017-06-30 |
$507 |
| 2017-03-31 |
$553 |
| 2016-12-31 |
$460 |
| 2016-09-30 |
$487 |
| 2016-06-30 |
$462 |
| 2016-03-31 |
$458 |
| 2015-12-31 |
$488 |
| 2015-09-30 |
$472 |
| 2015-06-30 |
$470 |
| 2015-03-31 |
$489 |
| 2014-12-31 |
$495 |
| 2014-09-30 |
$490 |
| 2014-06-30 |
$482 |
| 2014-03-31 |
$492 |
| 2013-12-31 |
$442 |
| 2013-09-30 |
$419 |
| 2013-06-30 |
$415 |
| 2013-03-31 |
$513 |
| 2012-12-31 |
$447 |
| 2012-09-30 |
$431 |
| 2012-06-30 |
$387 |
| 2012-03-31 |
$359 |
| 2011-12-31 |
$380 |
| 2011-09-30 |
$419 |
| 2011-06-30 |
$378 |
| 2011-03-31 |
$414 |
| 2010-12-31 |
$362 |
| 2010-09-30 |
$333 |
| 2010-06-30 |
$310 |
| 2010-03-31 |
$382 |
| 2009-12-31 |
$318 |
| 2009-09-30 |
$328 |
| 2009-06-30 |
$312 |
| 2009-03-31 |
$202 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$12.521B |
$3.350B |
|
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
|
